Catalyst Wire Dossier Catalyst Wire Dossier

Evolocumab

evolocumab · Amgen
Drug timelines are a Plus or Pro feature.

61 regulatory and trial events tracked for Evolocumab, covering 2015-09-22 to 2026-06-25. Get the full timeline:

Most recent: Clinical Trial Results: Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke [Phase 3]

See pricing